Lang Scott A.

CEO Scott Lang bought 1,160 shares of Anterix (ATEX) at $21.61 on 12/18, raising stake 16.3% to 8,260 shares amid 47.4% decline from 52-week high.

CEO Lang purchased 1,160 shares at $21.61 on 2025-12-18, increasing his holdings from 7,100 to 8,260 shares (+16.3% net change). This second purchase in 10 days (prior buy on 2025-12-08) comes as the stock trades -47.4% from its 52-week high of $41.99, though it has recovered +5.8% over the past 30 days. At the transaction price of $21.61, the stock was trading below the current price of $22.10, narrowing the gap between insider purchase price and current valuation. Notably, Lang's sole prior ATEX trade with measurable outcomes (Buy on 2025-09-18 at this ticker) posted a +0.3% 90-day return, and his cross-ticker track record across 2 prior buys shows a 100.00% 90-day win rate, though with modest average returns of +0.3%. The company's fundamentals present a paradox: revenue of $1.6M (latest quarter) with annual growth of +43.9%, and a P/E of 4.32, but the company was unprofitable over its most recent full fiscal year despite reporting net income of $53.5M in the latest quarter, suggesting potential quarterly volatility or timing distortions in profitability reporting.

ATEX CEO Lang Scott buys 2,450 shares at $20.41; holdings rise 52.7% to 7,100 shares.

Lang Scott A., President and CEO of Anterix Inc., purchased 2,450 shares at $20.41 on 2025-12-08, increasing his holdings by 52.7% from 4,650 to 7,100 shares. The company is trading at a P/E of 4.23 and recently reported net income of $53.5M against quarterly revenue of $1.6M, though full-year fundamentals remain negative. The stock is currently -48.5% from its 52-week high of $41.99 but has gained 19.1% in the past 30 days. This represents a meaningful accumulation by the CEO at a price materially below recent peaks, though his cross-ticker track record shows 1 prior buy averaging a -4.2% 30-day return, and his prior ATEX buy on 2025-09-18 also returned -4.2% over 30 days. The significance stems from the CEO's substantial increase in personal stake combined with the company's mixed financial profile (strong profitability offset by full-year losses) and current valuation proximity to 52-week lows.

CEO Lang Scott purchases 4,650 shares at $21.28 (stock now -47.0% from 52-week high of $41.99)

Lang Scott A., President and CEO, initiated a personal stake in Anterix by purchasing 4,650 shares at $21.28 on 2025-09-18, with zero prior holdings. The purchase occurs at a significant discount to the 52-week high of $41.99, representing a -47.0% pullback from peak valuations. While the company reported positive net income of $25,180,000.00 in its most recent quarter and strong annual revenue growth of +43.9%, it was unprofitable on a full-year basis, suggesting recent-quarter profitability may not be sustained or reflects a turnaround inflection. At current price of $22.25 (only 4.8% above purchase) and the company trading at P/E of 14.17 with a $417.0M market cap, the CEO's first personal purchase carries mixed signals: it shows executive confidence in recovery prospects, but the limited gain since execution and the divergence between quarterly and full-year profitability warrant scrutiny into whether Q3 results reflect durable margin improvement or cyclical strength.